Home / Recalls / New Life Pharma LLC / D-0395-2026

D-0395-2026 Class II Ongoing

Recalled by New Life Pharma LLC — Northvale, NJ

Recall Details

Product Type
Drugs
Report Date
March 11, 2026
Initiation Date
February 26, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
45 vials

Product Description

Tirzepatide Inj, 15mg x 4, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-04.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

OH

Code Information

Lot 240709, exp 7/31/2026

Other recalls by New Life Pharma LLC

  • D-0394-2026 Class II — Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley (February 26, 2026)
  • D-0393-2026 Class II — Semaglutide Inj., 2 mg x 5, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Va (February 26, 2026)
  • D-0392-2026 Class II — Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Val (February 26, 2026)